Cartesian Therapeutics
RNAC
#8958
Rank
NZ$0.34 B
Marketcap
NZ$11.22
Share price
4.24%
Change (1 day)
-12.95%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2026 (TTM): -NZ$90.98 Million

According to Cartesian Therapeutics's latest financial reports the company's current earnings are NZ$1.47 Million. In 2025 the company made an earning of -NZ$89.59 Million a decrease over its 2024 earnings that were of -NZ$49.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$90.98 Million1.55%
2025 -NZ$89.59 Million80.63%
2024 -NZ$49.6 Million-88.5%
2023 -NZ$0.44 Billion-724%
2022 NZ$69.1 M-649.67%
2021 -NZ$12.58 Million-89.78%
2020 -NZ$0.13 Billion25.06%
2019 -NZ$98.41 Million-15.68%
2018 -NZ$0.12 Billion-0.43%
2017 -NZ$0.12 Billion83.41%
2016 -NZ$63.91 Million44.3%
2015 -NZ$44.29 Million